The Biden Administration has announced further limits on Chinese firms’ ability to access foreign (read: US dominated) semiconductor technology. Many of my followers ask why I don’t consider China a more capable potential threat to the global order than I do; the ability for Beijing to be cut off from global technology with what amounts to the stroke of a pen is one of them.
China remains utterly dependent on foreign countries for innovation and tech discovery, research, investment into its higher level manufacturing. It’s not just that the most advanced chips powering everything from your smart phone to the cloud and advanced computing are designed in the West (and primarily the US)–key production components and technologies, such as advanced lasers, are often siloed within one or two companies in the US, the Netherlands/EU, or Japan and South Korea. While China might produce the lion’s share of low end chips, they are hardly at the forefront of anything.
Peter Zeihan is a world expert in geopolitics: the study of how place impacts financial, economic, cultural, political and military developments. He presents customized executive briefings to a wide array of audiences which include, but are not limited to, financial professionals, Fortune 500 firms, energy investors, and a mix of industrial, power, agricultural and consulting associations and corporations. Mr. Zeihan has been featured in, and cited by, numerous newspapers and broadcasts including The Wall Street Journal, Forbes, AP, Bloomberg, CNN, ABC, The New York Times, Fox News and MarketWatch.
But we also believe in doing good in the world. Here at Zeihan On Geopolitics we select a single charity to sponsor.
Our chosen charity is a group called Medshare, which provides emergency medical services to communities in need, with a very heavy emphasis on locations facing acute crises. Medshare operates right in the thick of it. Until future notice, every cent we earn from every book we sell in every format through every retailer is going to Medshare’s Ukraine fund.
We hope you’ll look up MedShare and consider a contribution to their efforts.
